Fig. 2From: FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarctionHypoxia restrained the expression of FNDC5 of BM-MSCs. a, c Representative Western blot results in BM-MSCs. b, d Semi-quantification of FNDC5 expression. Data are expressed as the mean ± SEM; n = 5; *p < 0.05Back to article page